Compounds > raloxifene hydrochloride
Page last updated: 2024-08-23

raloxifene hydrochloride and Myocardial Ischemia

raloxifene hydrochloride has been researched along with Myocardial Ischemia in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berkó, AM; Börzsei, D; Deim, Z; Gyöngyösi, M; Juhász, B; Kupai, K; Pávó, I; Posa, A; Szabó, R; Szilvássy, Z; Szűcs, G; Varga, C; Veszelka, M1
Atkins, JN; Bevers, TB; Cecchini, RS; Costantino, JP; Cronin, WM; Fehrenbacher, L; Ford, LG; Ganz, PA; James, J; Jordan, VC; Margolese, RG; McCaskill-Stevens, W; Pajon, ER; Reis, SE; Robidoux, A; Runowicz, CD; Vogel, VG; Wade, JL; Wickerham, DL; Wolmark, N1
Castro, M; Delgado, V; Duran, M; Marrugat, J; Morales, M; Reverter, JC; Roqué, M; Sala, J; Sitges, M; Subirana, I; Tàssies, D; Vila, J1
Egresits, J; Kordás, K; László, F; László, FA; Morschl, E; Nemcsik, J; Pávó, I1
Abe, A; Kawagoe, J; Kurachi, H; Ohmichi, M; Takahashi, K1
Atkins, JN; Bevers, TB; Cecchini, RS; Costantino, JP; Cronin, WM; Fehrenbacher, L; Ford, LG; Ganz, PA; James, J; Jordan, VC; Lippman, SM; Margolese, RG; McCaskill-Stevens, W; Pajon, ER; Reis, SE; Robidoux, A; Runowicz, CD; Vogel, VG; Wade, JL; Wickerham, DL; Wolmark, N1
Anderson, PW; Barrett-Connor, E; Cox, DA; Grady, D; Harper, KD; Hoszowski, K; Rautaharju, P; Sashegyi, A1

Reviews

1 review(s) available for raloxifene hydrochloride and Myocardial Ischemia

ArticleYear
[Cardiovascular effects of SERM].
    Clinical calcium, 2004, Volume: 14, Issue:10

    Topics: Apoptosis; Cell Cycle; Cyclin D1; Endothelium, Vascular; Estrogens; Gene Expression; Humans; Muscle, Smooth, Vascular; Myocardial Ischemia; Nitric Oxide; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Vasodilation

2004

Trials

4 trial(s) available for raloxifene hydrochloride and Myocardial Ischemia

ArticleYear
Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer.
    Cancer prevention research (Philadelphia, Pa.), 2010, Volume: 3, Issue:6

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Cataract; Double-Blind Method; Drug Utilization; Endometrial Neoplasms; Estrogens; Female; Follow-Up Studies; Fractures, Spontaneous; Humans; Incidence; Middle Aged; Myocardial Ischemia; Neoplasm Invasiveness; Neoplasms, Hormone-Dependent; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Risk; Selective Estrogen Receptor Modulators; Tamoxifen; Thromboembolism; Uterus

2010
[Effects of raloxifene on endothelial function and hemostasis in women with ischemic heart disease].
    Revista espanola de cardiologia, 2011, Volume: 64, Issue:7

    Topics: Aged; Blood Coagulation; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Female; Fibrinolysis; Hemostasis; Humans; Middle Aged; Muscle Tonus; Muscle, Smooth, Vascular; Myocardial Ischemia; Postmenopause; Raloxifene Hydrochloride; Sample Size; Selective Estrogen Receptor Modulators; Vasodilation

2011
Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.
    JAMA, 2006, Jun-21, Volume: 295, Issue:23

    Topics: Adult; Aged; Breast Neoplasms; Cataract; Cause of Death; Double-Blind Method; Female; Fractures, Bone; Humans; Incidence; Middle Aged; Myocardial Ischemia; Raloxifene Hydrochloride; Risk; Selective Estrogen Receptor Modulators; Tamoxifen; Thrombosis; Uterine Neoplasms

2006
Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial.
    JAMA, 2002, Feb-20, Volume: 287, Issue:7

    Topics: Aged; Cardiovascular Diseases; Double-Blind Method; Female; Humans; Ischemic Attack, Transient; Lipoproteins; Myocardial Ischemia; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Risk Assessment; Selective Estrogen Receptor Modulators; Stroke; Survival Analysis

2002

Other Studies

2 other study(ies) available for raloxifene hydrochloride and Myocardial Ischemia

ArticleYear
Cardioprotective Effect of Selective Estrogen Receptor Modulator Raloxifene Are Mediated by Heme Oxygenase in Estrogen-Deficient Rat.
    Oxidative medicine and cellular longevity, 2017, Volume: 2017

    Topics: Animals; Cardiotonic Agents; Estrogens; Female; Gene Expression Regulation, Enzymologic; Heme Oxygenase (Decyclizing); Myocardial Ischemia; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Wistar; Receptors, Estrogen

2017
Raloxifene lowers ischaemia susceptibility by increasing nitric oxide generation in the heart of ovariectomized rats in vivo.
    European journal of pharmacology, 2004, Jul-14, Volume: 495, Issue:2-3

    Topics: Administration, Oral; Animals; Blood Pressure; Calcium; Enzyme Inhibitors; Epinephrine; Estradiol; Female; Myocardial Ischemia; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Ornipressin; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Wistar; Selective Estrogen Receptor Modulators; Time Factors

2004